Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Overview of attention for article published in Blood Advances, October 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 32 X users

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 35 X posts from 32 X users, with an upper bound of 79,813 followers.

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR https://t.co/zfQGb807Wf - Note the patient population is relapsed or refractory B-cell lymphoma

RT @bmtdoc63: Infection after CAR T. My approach: 1. If ANC<500: Levaquin+Fluconazole 2. IVIG if IGG<400 3. Valtrex and PJP prophylaxis if…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 31 additional X posts.